Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 38.98 Delayed Data As of Dec 02 |  +0.29 / +0.75%Today’s Change | 18.47 Today|||52-Week Range 93.96 | +47.82% Year-to-Date |
Latest RETA News | Press Releases
No recent news for Reata Pharmaceuticals Inc.
Today’s Trading
| Previous close | 38.69 |
| Today’s open | 37.43 |
| Day’s range | 37.32 - 39.18 |
| Volume | 47,308 |
| Average volume (3 months) | 892,763 |
| Market cap | $1.4B |
Data as of 4:00pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | -11.40% |
| Earnings growth (this year) | -2.74% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +27.40% |
| P/E ratio | NM |
| Price/Sales | 83.36 |
| Price/Book | 7.60 |
Competitors
Data as of 4:00pm ET, 12/02/2022
Financials
| Next reporting date | March 3, 2023 |
| EPS forecast (this quarter) | -$2.19 |
| Annual revenue (last year) | $11.5M |
| Annual profit (last year) | -$297.4M |
| Net profit margin | -2,588.22% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plano, Texas |
Forecasts
